SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-004580
Filing Date
2022-01-07
Accepted
2022-01-07 17:16:01
Documents
14
Period of Report
2022-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200059d8k.htm   iXBRL 8-K 32749
2 EX-99.1 d200059dex991.htm EX-99.1 17788
6 GRAPHIC g200059g0108004628938.jpg GRAPHIC 3059
  Complete submission text file 0001193125-22-004580.txt   184387

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20220107.xsd EX-101.SCH 2524
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20220107_lab.xml EX-101.LAB 18034
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20220107_pre.xml EX-101.PRE 11318
8 EXTRACTED XBRL INSTANCE DOCUMENT d200059d8k_htm.xml XML 3612
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 22518941
SIC: 2834 Pharmaceutical Preparations